Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|May 27, 2019
Utilizing comprehensive and mini-kinome panels to optimize the selectivity of quinoline inhibitors for cyclin G associated kinase (GAK)Christopher R M Asquith, Daniel K Treiber, William J ZuercherNature Biotechnology|November 1, 2011
Comprehensive analysis of kinase inhibitor selectivityMindy I Davis, Jeremy P Hunt, Sanna Herrgard, et al.Chemistry & Biology|November 25, 2010
Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistryLisa M Wodicka, Pietro Ciceri, Mindy I Davis, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AC710, a Globally Selective Inhibitor of Platelet-Derived Growth Factor Receptor-Family KinasesGang Liu, Brian T Campbell, Mark W Holladay, et al.Cancer Research|January 21, 2006
Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the Aurora kinase inhibitor VX-680Matthew A Young, Neil P Shah, Luke H Chao, et al.Nature Chemical Biology|March 4, 2014
Dual kinase-bromodomain inhibitors for rationally designed polypharmacologyPietro Ciceri, Susanne Müller, Alison O'Mahony, et al.Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Arylcarboxyamino-substituted diaryl ureas as potent and selective FLT3 inhibitorsHitesh K Patel, Robert M Grotzfeld, Andiliy G Lai, et al.Bioorganic & Medicinal Chemistry Letters|August 2, 2011
Novel series of pyrrolotriazine analogs as highly potent pan-Aurora kinase inhibitorsSunny Abraham, Michael J Hadd, Lan Tran, et al.Journal of Medicinal Chemistry|March 3, 2012
Discovery of highly potent and selective pan-Aurora kinase inhibitors with enhanced in vivo antitumor therapeutic indexGang Liu, Sunny Abraham, Lan Tran, et al.Pageof 2